{"nctId":"NCT00433199","briefTitle":"Testosterone Treatment for Hypogonadal Men","startDateStruct":{"date":"2007-02"},"conditions":["Hypogonadism"],"count":274,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"T-Gel 1.62%","type":"EXPERIMENTAL","interventionNames":["Drug: Testosterone (T) Gel 1.62%"]}],"interventions":[{"name":"Testosterone (T) Gel 1.62%","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Low T males 18 - 80 years of age\n\nExclusion Criteria:\n\n* Normal T levels\n* Elevated Prostatic Specific Antigen (PSA)","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Subjects on Testosterone Treatment Achieving Target Range for Testosterone Cav (Time-averaged Concentration Over the Dosing Interval of 24 Hours) on Day 112","description":"Cav results were required to fall within the normal range of 300-1000 ng/dL. Success in the study was defined as \\>=75% of subjects on active treatment within the normal serum testosterone concentration range of 300-1000 ng/dL. In addition, the lower bound of the 95% CI was to be not less than 65% based on the Day 112 Parmacokinetics (PK) results","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81.6","spread":null},{"groupId":"OG001","value":"37.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects on Testosterone Treatment Achieving Target Range for Testosterone Cav (Time-averaged Concentration Over the Dosing Interval of 24 Hours) on Day 14","description":"Cav results were required to fall within the normal range of 300-1000 ng/dL at Day 14. Success was defined as \\>=75% of subjects on active treatment within the normal serum testosterone concentration range of 300-1000 ng/dL. In addition, the lower bound of the 95% CI was to be not less than 65% based on the Day 14 PK results","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65.7","spread":null},{"groupId":"OG001","value":"29.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects on Testosterone Treatment Achieving Target Range for Testosterone Cav (Time-averaged Concentration Over the Dosing Interval of 24 Hours) on Day 56","description":"Cav results were required to fall within the normal range of 300-1000 ng/dL at Day 56. Success was defined as \\>=75% of subjects on active treatment within the normal serum testosterone concentration range of 300-1000 ng/dL. In addition, the lower bound of the 95% CI was to be not less than 65% based on the Day 56 PK results","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82.5","spread":null},{"groupId":"OG001","value":"34.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects on Testosterone Treatment Achieving Target Range for Testosterone Cav (Time-averaged Concentration Over the Dosing Interval of 24 Hours) on Day 182","description":"Cav results were required to fall within the normal range of 300-1000 ng/dL at Day 182. Success was defined as \\>=75% of subjects on active treatment within the normal serum testosterone concentration range of 300-1000 ng/dL. In addition, the lower bound of the 95% CI was to be not less than 65% based on the Day 182 PK results.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82.2","spread":null},{"groupId":"OG001","value":"28.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Target Range for Testosterone Cav During the Open-label Period at Day 266.","description":"The success at Day 266 was defined as \\>=75% of subjects within the normal serum total testosterone concentration range of 300-1000 ng/dL. The Lower bounds of the 95% CI was to be not less than 65%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.4","spread":null},{"groupId":"OG001","value":"69.2","spread":null},{"groupId":"OG002","value":"77.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Target Range for Testosterone Cav During the Open-label Period at Day 364.","description":"The success at Day 364 was defined as \\>=75% of subjects within the normal serum total testosterone concentration range of 300-1000 ng/dL. The Lower bounds of the 95% CI was to be not less than 65%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77.9","spread":null},{"groupId":"OG001","value":"87.0","spread":null},{"groupId":"OG002","value":"79.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":40},"commonTop":["Cell marker procedures","Upper respiratory tract infections","Headaches NEC","Bacterial infections NEC"]}}}